Findings from Teva Pharmaceuticals Provide New Insights into Breast Cancer (A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel)

Source :: Biotech Week. February 24, 2016, 476
Publication Year :: 2016
Abstract: 2016 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Investigators discuss new findings in Oncology. According to news reporting originating from Netanya, Israel, by [...]

Subjects :: Teva Pharmaceutical Industries Ltd.
Drug therapy
Research
Anthracyclines -- Research
Cancer research
Chemotherapy
Pharmaceutical industry
Cancer patients -- Drug therapy
Breast cancer -- Research -- Drug therapy
Docetaxel -- Research

Tools